Radioisotope uptake in hybrid PET/MR system:comparison with PET/CT

Radioisotope uptake in hybrid PET/MR system:comparison with PET/CT - Radioisotope uptake in PET/MR

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014499

Enrollment

150

Registered

2014-07-08

Start date

2014-07-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignancies Epilepsy Cardial fairue, Cardiac Salcoidosis

Interventions

Hybrid PET/MR system

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who undergo PET/CT for clinical purpose 2. Inclusion: malignancies (except for early gastric cancer), intractable partial epilepsy, Cardiac failure or Cardiac sarcoidosis 3. no limit for age, both males and females 4. Written informed consent is obtained by adults patients 5. Written informed consent is obtained by guardians of pediatric patients

Exclusion criteria

Exclusion criteria: 1. contraindication of PET pregnant claustrophobia 2. contraindication of MR cardiac pacemaker cochlear implant artificial heart valve history of surgery for cerebral aneurisms dentures tattoo metallic foreign body claustrophobia

Design outcomes

Primary

Measure	Time frame
Standardized uptake value (SUV) of radioisotope in lesions and normal tissues	—

Secondary

Measure	Time frame
Histological grades and stage of malignant tumors Myocardial viability and diagnostic performance for cardiac sarcoidosis.	—

Countries

Japan

Contacts

Public ContactOsamu Togao

Graduate School of Medical Sciences Department of Clinical Radiology

togao@radiol.med.kyushu-u.ac.jp092-642-5695

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026